skip to main content

S. 778: Prescription Drug Monitoring Act of 2017

A bill to require the use of prescription drug monitoring programs and to facilitate information sharing among States.

The bill’s titles are written by its sponsor.

What you can do

Overview

Introduced:

Mar 30, 2017

Status:

Introduced on Mar 30, 2017

This bill is in the first stage of the legislative process. It was introduced into Congress on March 30, 2017. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Sponsor:

Amy Klobuchar

Senior Senator from Minnesota

Democrat

Text:

Read Text »
Last Updated: Mar 30, 2017
Length: 6 pages

Prognosis:

2% chance of being enacted according to Skopos Labs (details)

History

Mar 30, 2017
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Pending
 
Ordered Reported

Pending
 
Passed Senate (House next)

Pending
 
Passed House

Pending
 
Signed by the President

S. 778 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 778 — 115th Congress: Prescription Drug Monitoring Act of 2017.” www.GovTrack.us. 2017. September 23, 2017 <https://www.govtrack.us/congress/bills/115/s778>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.